Pulmonary vasodilator action of tolazoline

B. W. Goetzman, Jay M Milstein

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The pulmonary vasodilator action of tolazoline in newborn lambs was shown to be mediated via histamine receptors. Maximal changes in pulmonary vascular resistance, ΔPVR, were calculated as percents of the base line value %ΔPVR. The mean %ΔPVR after tolazoline, 1 mg/kg, was -25 ± 4% for eight lambs. Four lambs then received the histamine H1 receptor antagonist, diphenhydramine, and the mean %ΔPVR due to tolazoline was - 12 ± 4%. Four lambs received the H2 receptor antagonist, metiamide, and the mean %ΔPVR due to tolazoline was -18 ± 5%. After both H1 and H2 antagonists, the mean %ΔPVR due to tolazoline was +6 ± 8%. Therefore, both histamine H1 and H2 receptors were involved in the vasodilator response to tolazoline. If the pulmonary vasodilator action of tolazoline is mediated by histamine receptors in human infants, as it is in newborn lambs, it may be possible to select a more specific therapeutic agent for infants with pulmonary vasospasm. Histamine, 2 methylhistamine, a specific H1 agonist, or 4 methylhistamine, a specific H2 agonist, may be such agents in certain situations.

Original languageEnglish (US)
Pages (from-to)942-944
Number of pages3
JournalPediatric Research
Volume13
Issue number8
StatePublished - 1979

Fingerprint

Tolazoline
Vasodilator Agents
Lung
Histamine Agonists
Histamine Receptors
Histamine H2 Receptors
Metiamide
Newborn Infant
Histamine H1 Antagonists
Diphenhydramine
Histamine H1 Receptors
Vascular Resistance
Histamine

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Pulmonary vasodilator action of tolazoline. / Goetzman, B. W.; Milstein, Jay M.

In: Pediatric Research, Vol. 13, No. 8, 1979, p. 942-944.

Research output: Contribution to journalArticle

Goetzman, BW & Milstein, JM 1979, 'Pulmonary vasodilator action of tolazoline', Pediatric Research, vol. 13, no. 8, pp. 942-944.
Goetzman, B. W. ; Milstein, Jay M. / Pulmonary vasodilator action of tolazoline. In: Pediatric Research. 1979 ; Vol. 13, No. 8. pp. 942-944.
@article{70b6aad573b44819ae3328e83d504975,
title = "Pulmonary vasodilator action of tolazoline",
abstract = "The pulmonary vasodilator action of tolazoline in newborn lambs was shown to be mediated via histamine receptors. Maximal changes in pulmonary vascular resistance, ΔPVR, were calculated as percents of the base line value {\%}ΔPVR. The mean {\%}ΔPVR after tolazoline, 1 mg/kg, was -25 ± 4{\%} for eight lambs. Four lambs then received the histamine H1 receptor antagonist, diphenhydramine, and the mean {\%}ΔPVR due to tolazoline was - 12 ± 4{\%}. Four lambs received the H2 receptor antagonist, metiamide, and the mean {\%}ΔPVR due to tolazoline was -18 ± 5{\%}. After both H1 and H2 antagonists, the mean {\%}ΔPVR due to tolazoline was +6 ± 8{\%}. Therefore, both histamine H1 and H2 receptors were involved in the vasodilator response to tolazoline. If the pulmonary vasodilator action of tolazoline is mediated by histamine receptors in human infants, as it is in newborn lambs, it may be possible to select a more specific therapeutic agent for infants with pulmonary vasospasm. Histamine, 2 methylhistamine, a specific H1 agonist, or 4 methylhistamine, a specific H2 agonist, may be such agents in certain situations.",
author = "Goetzman, {B. W.} and Milstein, {Jay M}",
year = "1979",
language = "English (US)",
volume = "13",
pages = "942--944",
journal = "Pediatric Research",
issn = "0031-3998",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Pulmonary vasodilator action of tolazoline

AU - Goetzman, B. W.

AU - Milstein, Jay M

PY - 1979

Y1 - 1979

N2 - The pulmonary vasodilator action of tolazoline in newborn lambs was shown to be mediated via histamine receptors. Maximal changes in pulmonary vascular resistance, ΔPVR, were calculated as percents of the base line value %ΔPVR. The mean %ΔPVR after tolazoline, 1 mg/kg, was -25 ± 4% for eight lambs. Four lambs then received the histamine H1 receptor antagonist, diphenhydramine, and the mean %ΔPVR due to tolazoline was - 12 ± 4%. Four lambs received the H2 receptor antagonist, metiamide, and the mean %ΔPVR due to tolazoline was -18 ± 5%. After both H1 and H2 antagonists, the mean %ΔPVR due to tolazoline was +6 ± 8%. Therefore, both histamine H1 and H2 receptors were involved in the vasodilator response to tolazoline. If the pulmonary vasodilator action of tolazoline is mediated by histamine receptors in human infants, as it is in newborn lambs, it may be possible to select a more specific therapeutic agent for infants with pulmonary vasospasm. Histamine, 2 methylhistamine, a specific H1 agonist, or 4 methylhistamine, a specific H2 agonist, may be such agents in certain situations.

AB - The pulmonary vasodilator action of tolazoline in newborn lambs was shown to be mediated via histamine receptors. Maximal changes in pulmonary vascular resistance, ΔPVR, were calculated as percents of the base line value %ΔPVR. The mean %ΔPVR after tolazoline, 1 mg/kg, was -25 ± 4% for eight lambs. Four lambs then received the histamine H1 receptor antagonist, diphenhydramine, and the mean %ΔPVR due to tolazoline was - 12 ± 4%. Four lambs received the H2 receptor antagonist, metiamide, and the mean %ΔPVR due to tolazoline was -18 ± 5%. After both H1 and H2 antagonists, the mean %ΔPVR due to tolazoline was +6 ± 8%. Therefore, both histamine H1 and H2 receptors were involved in the vasodilator response to tolazoline. If the pulmonary vasodilator action of tolazoline is mediated by histamine receptors in human infants, as it is in newborn lambs, it may be possible to select a more specific therapeutic agent for infants with pulmonary vasospasm. Histamine, 2 methylhistamine, a specific H1 agonist, or 4 methylhistamine, a specific H2 agonist, may be such agents in certain situations.

UR - http://www.scopus.com/inward/record.url?scp=0018376108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018376108&partnerID=8YFLogxK

M3 - Article

VL - 13

SP - 942

EP - 944

JO - Pediatric Research

JF - Pediatric Research

SN - 0031-3998

IS - 8

ER -